Frontage Laboratories

Frontage Holdings Corporation is a contract research organization that offers a comprehensive range of research, analytical, and development services to pharmaceutical, biotechnology, and agrochemical companies. Established in 2018 and headquartered in Exton, Pennsylvania, the company supports drug discovery and development through services such as drug metabolism, pharmacokinetics, safety and toxicology, and bioanalytical testing. Additionally, Frontage provides product development and bioequivalence services that assist generic and consumer health pharmaceutical firms in their regulatory submissions. With operations in North America, including the United States and Canada, as well as in the People's Republic of China and other global markets, Frontage Holdings aims to facilitate the advancement of biopharmaceutical research and development from early stages to late-stage clinical trials. The company is a subsidiary of Hong Kong Tigermed Co., Limited.

John Lin

President

Abdul Mutlib

CEO

6 past transactions

Nucro-Technics

Acquisition in 2023
Nucro-Technics is a contract research organization that provides a range of support services for pharmaceutical, biologic, and medical device companies. The company specializes in clinical trial support, product testing, and stability studies, as well as consulting services. Its capabilities include analytical chemistry testing, microbiology testing, toxicology services, bioanalytical services, genetic toxicology services, and medical device testing. By partnering with various companies in the healthcare sector, Nucro-Technics aims to facilitate the development and approval of new products through comprehensive research and testing solutions.

Heyan Biotech

Acquisition in 2021
Heyan Biotech is a national biotech industry base, provides for target based in vitro pharmacodynamic screening and early pharmacological pharmacodynamic evaluation services in early drug discovery.

Ocean Ridge Biosciences

Acquisition in 2021
Ocean Ridge Biosciences is a life science company based in Deerfield Beach, Florida, specializing in genomic services for the health care and life science sectors. The company focuses on the extraction and analysis of RNA and proteins from diverse biological samples, utilizing a real-time PCR platform to facilitate accurate and affordable research. As demand for high-quality genomic services continues to grow for both research and clinical applications, Ocean Ridge Biosciences aims to support researchers in making informed, data-driven decisions. Its strategic location within a major metropolitan area allows for easy access to leading research universities, institutes, and hospitals, enhancing its collaborative potential within the biotechnology field.

Acme Bioscience

Acquisition in 2020
Acme Bioscience is a biological research and development organization based in Palo Alto, California, specializing in a range of chemistry services tailored for biopharmaceutical companies. The company offers discovery chemistry, medicinal chemistry, and process chemistry research and development, along with chemical manufacturing services. Acme Bioscience has significant expertise in antiviral and antibacterial research, as well as in the synthesis of nucleotides, nucleosides, triphosphates, pro-drugs, heterocycles, and boron-containing compounds. In addition to these services, the company provides custom synthesis, biological tests, and analytical services, including X-ray analysis. Acme collaborates closely with clients to address complex medicinal challenges and facilitate the development of new chemical entities.

Concord Biosciences

Acquisition in 2018
Concord Biosciences provides a range of non-clinical discovery support and integrated research and development services aimed at facilitating drug candidate development from lead identification to regulatory submission. The company's capabilities encompass early pharmacokinetic and metabolism screening, pilot toxicology evaluations, and IND/NDA-enabling toxicology and DMPK development for both small molecules and biologics. Additionally, Concord offers synthetic, medicinal, and process chemistry services, along with radiochemistry and cGMP API manufacturing, supporting both small-scale clinical batches and commercial API production. By employing experienced scientists, Concord aims to accelerate the drug development process, enabling faster transition from compound lead selection to regulatory filing. Operating from a single research site in Concord, Ohio, the company is equipped to handle projects of various sizes and complexities, delivering integrated services tailored to meet the needs of its clients in the pharmaceutical and agricultural chemicals sectors.

BDM Consulting

Acquisition in 2015
BDM Consulting is an independent CRO specializing in biostatistics. SAS programming, and data management. BDM is composed of a group of more than 35 critical talents/experts, who excel and stand out among their peers in the industry. Its clients and partners include pharmaceutical, biotechnology, medical device companies and CROs. Striving to high quality, BDM focuses on reducing the time, cost and risk of bringing new pharmaceutical products to market.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.